GigaGen Inc.’s co-founder and Chief Executive Officer, explained that for decades scientists working with emerging pathogens had been concerned about the possibility of a pandemic, especially since funding decisions seemed more focused on the disease in question than the possible advantages a developing technology could provide. While many researchers may have redirected their work towards combatting COVID-19, teams also took a fresh look at various other conditions, including neglected diseases and neuroscience.